Management of genital warts

CM Kodner, S Nasraty - American family physician, 2004 - aafp.org
Genital warts caused by human papillomavirus infection are encountered commonly in
primary care. Evidence guiding treatment selection is limited, but treatment guidelines …

Genital warts: current and future management options

C O'Mahony - American journal of clinical dermatology, 2005 - Springer
Genital warts are a cosmetic nuisance. They are caused by low-risk human papillomavirus
types, have no oncogenic potential and are not linked to cervical cancer. However, they …

Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with …

ML Murray, J Meadows, CJ Doré, AJ Copas… - BMC medical research …, 2018 - Springer
Background Anogenital warts are the second most common sexually transmitted infection
diagnosed in sexual health services in England. About 90% of genital warts are caused by …

The treatment of human papillomavirus lesions of the lower genital tract

C Sonnex, CJN Lacey - Best practice & research Clinical obstetrics & …, 2001 - Elsevier
Anogenital warts are caused by human papillomavirus types 6 and 11 infection, and are the
most common clinical manifestation of lower genital tract human papillomavirus infection …

The role of imiquimod 3.75% cream in the treatment of external genital warts.

B Berman, J Wolf - Skin Therapy Letter, 2012 - europepmc.org
Imiquimod 3.75% cream has recently been approved by both the US Federal Drug
Administration and Health Canada for the treatment of external genital warts. Herein, we …

Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations

DN Sauder, RB Skinner, TL Fox… - Sexually transmitted …, 2003 - journals.lww.com
Topical Imiquimod 5% Cream as an Effective Treatment for Ext... : Sexually Transmitted Diseases
Topical Imiquimod 5% Cream as an Effective Treatment for External Genital and Perianal Warts …

Human papillomavirus: burden of illness and treatment cost considerations

PA Fox, MY Tung - American journal of clinical dermatology, 2005 - Springer
The monetary and personal costs to society of human papillomavirus (HPV) infection are
enormous. In order to make a comparison of different treatment methods we reviewed the …

Treatment of external genital warts in men with imiquimod 2% in cream. A placebo-controlled, double-blind study

TA Syed, SM Hadi, ZA Qureshi, SM Ali, MS Kwah - Journal of Infection, 2000 - Elsevier
Objective: The purpose of this double-blind, placebo-controlled study was to evaluate the
safety, clinical efficacy and tole-rability of imiquimod (2%) in cream to cure external genital …

Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day

KH Fife, A Ferenczy, JM Douglas Jr… - Sexually transmitted …, 2001 - journals.lww.com
Background Medical therapy for genital warts remains suboptimal. The topical interferon and
cytokine inducer, imiquimod, has been proved effective for the treatment of external genital …

An open-label phase II pilot study investigating the optimal duration of imiquimod 5% cream for the treatment of external genital warts in women

SM Garland, R Waddell, A Mindel… - … journal of STD & …, 2006 - journals.sagepub.com
Our objective was to determine the optimal duration of treatment with imiquimod for external
genital warts over 4, 8, 12 or 16 weeks. A total of 120 women with a history of genital warts …